Drug Profile
Research programme: nitric oxide-donating compounds - NicOx
Alternative Names: HCT 2037; NCX 1236; NCX 226; NCX 429; NCX 6550; NCX 8001; NCX 976Latest Information Update: 31 Jul 2012
Price :
$50
*
At a glance
- Originator NicOx
- Class Nitrates
- Mechanism of Action Cyclooxygenase inhibitors; Endothelin receptor antagonists; Nitric oxide donors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- Discontinued Bacterial infections; Cancer; Diabetic retinopathy; Hypertension; Inflammation; Metabolic disorders; Osteoarthritis; Pain; Pulmonary arterial hypertension; Viral infections
Most Recent Events
- 27 Jul 2012 Discontinued - Preclinical for Inflammation in France (unspecified route)
- 27 Jul 2012 Discontinued - Preclinical for Pulmonary hypertension in France (unspecified route)
- 27 Jul 2012 Discontinued for Diabetic retinopathy in France (unspecified route)